NDC 72611-716
Dexrazoxane
Dexrazoxane For Injection
Dexrazoxane is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Almaject, Inc.. The primary component is Dexrazoxane Hydrochloride.
| Product ID | 72611-716_0b8f1ae8-7686-a03b-75cb-a24ee2dd4f98 |
| NDC | 72611-716 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexrazoxane |
| Generic Name | Dexrazoxane For Injection |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207321 |
| Labeler Name | Almaject, Inc. |
| Substance Name | DEXRAZOXANE HYDROCHLORIDE |
| Active Ingredient Strength | 500 mg/50mL |
| Pharm Classes | Cytoprotective Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |